T2 Biosystems, Inc
TTOO
TTOO was delisted on the 11th of February, 2025.
26 hedge funds and large institutions have $366K invested in T2 Biosystems, Inc in 2024 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 5 increasing their positions, 4 reducing their positions, and 4 closing their positions.
125% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 4
25% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 4
24% more funds holding
Funds holding: 21 → 26 (+5)
91% less capital invested
Capital invested by funds: $4.24M → $366K (-$3.87M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$116K |
| 2 |
Squarepoint
New York
|
+$77.7K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$42.9K |
| 4 |
VF
Virtu Financial
New York
|
+$26K |
| 5 |
TSS
Two Sigma Securities
New York
|
+$19.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
-$2.75M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$197K |
| 3 |
Millennium Management
New York
|
-$77.1K |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$3.12K |
| 5 |
Osaic Holdings
Scottsdale,
Arizona
|
-$140 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
26
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | -$3.12K | -3,730 | -93% |
|
27
Barclays
London,
United Kingdom
| – | -$84 | -100 | -99% |
|
|
IAIM
28
International Assets Investment Management
Orlando,
Florida
| – | -$33 | -65 | Closed |
|
|
IA
29
IFP Advisors
Tampa,
Florida
| – | -$2 | -1 | Closed |
|
TTOO Hedge Fund Activity: Q4 2024 in Review
26 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in T2 Biosystems, Inc (TTOO) for Q4 2024, worth a combined $366K — down 91% from $4.24M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new TTOO positions and 4 closed out — a net gain of 5 holders — while 5 added to existing stakes and 4 trimmed.
The largest buyer was UBS Group, adding an estimated $116K. The largest seller was Armistice Capital, exiting entirely with an estimated $2.75M sold.
- 26 institutional investors held T2 Biosystems, Inc (TTOO) as of Q4 2024, up from 21 in Q3 2024.
- Funds reported $366K of T2 Biosystems, Inc stock for Q4 2024, down 91% quarter-over-quarter.
- 9 funds opened new T2 Biosystems, Inc positions in Q4 2024 and 4 closed out, a net change of +5 holders.
- The largest T2 Biosystems, Inc buyer in Q4 2024 was UBS Group, an estimated $116K added.
- The largest T2 Biosystems, Inc seller in Q4 2024 was Armistice Capital, an estimated $2.75M sold.
Based on aggregated 13F filings for Q4 2024.